Madrigal Pharmaceuticals Announces Completion of Enrollment in Phase 3 MAESTRO NAFLD-1 Trial and Reports 2020 Third Quarter Financial Results and Highlights

NEXT STORY
RedHill Biopharma to Host Third Quarter Financial Results and Business Highlights Webcast on November 12, 2020
PREV STORY
ProMIS Neurosciences Closes First Tranche of Private Placement
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioXcel Therapeutics to Present at the BofA Securities Virtual Health Care Conference

author_avatar
NASDAQ Market News

Aptose Enters into $15.5 Million Common Shares Purchase Agreement with Aspire Capital Fund, LLC

SAN DIEGO and TORONTO, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” ...

author_avatar
NASDAQ Market News

New Patient-Centered Program Launched for New York Primary Care Practices

WASHINGTON, DC, April 03, 2018 (GLOBE NEWSWIRE) -- The National Committee for Quality Assurance ...

author_avatar
NASDAQ Market News